Published August 27, 2026 · updated August 27, 2026 · medically reviewed by Dr. S. Shuwart, MD on August 27, 2026

Medically reviewed · August 27, 2026

Beyond-use dates for compounded GLP-1 vials

What a beyond-use date is, how compounding pharmacies assign it, why it matters for multi-month supplies and dose tiers, and what to check on the label.

What it is

A beyond-use date (BUD) is the date after which a compounded preparation must not be used, assigned by the compounding pharmacy according to USP standards, the preparation’s category, the conditions under which it was made, and any stability or sterility testing performed. It is not the same as a manufacturer’s expiry date on an approved product, and it is usually much shorter.

Why it matters for GLP-1 vials

Compounded GLP-1s are typically dispensed as multi-dose vials meant to last weeks. In our dataset, providers state beyond-use periods such as five weeks for a monthly vial and longer for extended-supply plans. Two consequences follow. A vial sold as an “8–10 week supply” must have a BUD that covers that period at the expected dose; and a patient who stays on a low dose and stretches a vial past the date is using medication the pharmacy no longer vouches for. Plan tickets on this site show the beyond-use days a provider publishes.

Storage

Compounded GLP-1 vials are generally refrigerated; the pharmacy label states the conditions and the BUD assumes them. A shipment that arrives warm is a question for the pharmacy, not something to judge by appearance; the shipping policy tracker records what providers say about replacement.

What to check on the label

The pharmacy’s name, the concentration (mg/mL), the total volume, the beyond-use date, the storage instructions and the patient’s name. If any is missing, ask before using it.

Questions this page answers

Can I keep using a vial after its beyond-use date if it looks fine?
No. The date reflects the period for which the pharmacy assigned sterility and potency; appearance tells you nothing about either.

Sources

  1. USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations (standard)
  2. Verified plan records with beyond-use days (provider)

Related: /guides/compounded-glp1-safety/ /guides/how-to-verify-a-compounding-pharmacy/ /pricing/tirzepatide/

Educational information, not medical advice. Decisions about GLP-1 medication belong with you and a licensed clinician who knows your history. Compounded medications are not FDA-approved. Report an error.